Ayman M. Alameen

Sakakah, 72388, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Targeting the hsa-miR-155-5p-BACH1-MMP-9 Signaling Hub in Lung Cancer: A Novel Anticancer Mechanism of Thymoquinone.

Targeting the hsa-miR-155-5p-BACH1-MMP-9 Signaling Hub in Lung Cancer: A Novel Anticancer Mechanism of Thymoquinone.

Journal: Biomolecules
Published: May 12, 2026

Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities.

Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities.

Journal: Life sciences
Published: March 15, 2026

Repurposing niclosamide to mitigate inflammaging: a review of multi-target mechanisms in cellular senescence and age-related decline.

Repurposing niclosamide to mitigate inflammaging: a review of multi-target mechanisms in cellular senescence and age-related decline.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 05, 2026

SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential.

SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential.

Journal: Neuromolecular medicine
Published: February 11, 2026

Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline.

Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 03, 2026

NMR-based metabolomics analysis in breast cancer patients from Saudi Arabia: a pilot study.

NMR-based metabolomics analysis in breast cancer patients from Saudi Arabia: a pilot study.

Journal: Scientific reports
Published: January 24, 2026

Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.

Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects.

Journal: Nanoscale
Published: December 01, 2025

Interleukin-32: a Pandora's box in human immunodeficiency virus infection.

Interleukin-32: a Pandora's box in human immunodeficiency virus infection.

Journal: Frontiers in immunology
Published: September 19, 2025

Metformin as a Neuroendocrine Modulator in Catamenial Epilepsy: Interplay with Sex Hormones and Neurosteroids.

Metformin as a Neuroendocrine Modulator in Catamenial Epilepsy: Interplay with Sex Hormones and Neurosteroids.

Journal: Molecular neurobiology
Published: August 09, 2025

Mucoadhesive chitosan-coated boswellic acids nanoparticles as promising gastroprotective nanoagents via modulation of the RAS/ERK signaling pathway.

Mucoadhesive chitosan-coated boswellic acids nanoparticles as promising gastroprotective nanoagents via modulation of the RAS/ERK signaling pathway.

Journal: Discover nano
Published: July 04, 2025

Association of serum copper, zinc and copper to zinc ratio in patients with acute myeloid leukemia.

Association of serum copper, zinc and copper to zinc ratio in patients with acute myeloid leukemia.

Journal: Scientific reports
Published: April 29, 2025

Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation.

Citronellol silver nanoconjugates as a therapeutic strategy for glioblastoma through computational and experimental evaluation.

Journal: Scientific reports
Published: February 13, 2025
Showing 1-12 of 30

Last Updated: 09/26/2026